The largest database of trusted experimental protocols

13 protocols using cd8 clone sk1

1

PBMC Cytokine Response Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 2 to 4 × 106 human PBMCs expanded with specific Immuno-STAT or peptide were pretreated with brefeldin A (BFA) and monensin (ThermoFisher), plated in a 24-well plate, and stimulated at a 1:1 ratio with T2 cells (ATCC) that had been loaded with CMV pp65495–503 (NLVPMVATV) or Mart126–35 (ELAGIGILTV) or HIV-1 p17 Gag77–85 (SLYNTVATL; SL9) peptide for 2 h and washed twice. Cells were stimulated for 5 h, washed, stained with Fixed Viability Stain 780 (BD Biosciences), antibodies against CD3 (clone SK7, BioLegend), CD8 (clone SK1, BD Biosciences) and CD107a (clone H4A3, BD Biosciences), and fixed using IC fixation buffer (ThermoFisher). Cells were next washed in permeabilization buffer (eBioscience), stained with antibodies against TNF-α (clone MAb11, BD Biosciences), IFN-γ (clone 4S.B3, BioLegend), and granzyme B (clone GB11, BD Biosciences) for 30 min at room temperature, washed, and analyzed. For representative FACS plots and pairwise marker quantitation, PBMC were stimulated as described above using T2 cells loaded with 100 nM peptide. For peptide titration studies, PBMC were stimulated as described above using T2 cells loaded with 1 × 10–13, 1 × 10–12, 1 × 10–11, 1 × 10–10, 1 × 10–9, 1 × 10–8, 1 × 10–7, 1 × 10–6, or 1 × 10–5 g/ml peptide.
+ Open protocol
+ Expand
2

Multiparameter Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For all experiments, cells were stained with antibodies diluted in PBS/0.5% FBS in 1:50 V/V ratio at 4°C for 30 minutes. The following antibodies were used: CD4 (clone SK3), CD8 (clone SK1), CD134 (OX40, clone ACT35), CD137 (4-1BB, clone 4B4-1), and anti-mouse TCRβ Chain (clone H57-597) (BD Biosciences, San Jose, CA). Flow cytometric analysis was performed on FACS Canto I cell analyzer (BD Biosciences). Data was analyzed using FlowJo 10.2 software (TreeStar, Ashland, OR).
+ Open protocol
+ Expand
3

Multiparameter Flow Cytometry of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The phenotype of PBMCs cell subsets was evaluated by multiparameter flow cytometry. Cells were incubated in the dark for 20 min RT with the following panel of anti-human fluorescent labelled antibodies: CD3 (clone HIT3a, APC conjugated, BioLegend), CD4 (clone SK3, APC conjugated, eBiosciences), CD8 (clone SK1, APC conjugated, BD Biosciences), CD14 (clone 61D3, FITC conjugated, eBiosciences), CD25 (clone BC96, Alexa Fluor 488 conjugated, eBiosciences), CD69 (clone FN50, PE conjugated, eBiosciences), CD45 (clone L48, PerCyP conjugated, BD Biosciences), Foxp3 (clone PCH101, PE conjugatated, eBiosciences), IL-1β (clone CRM56, FITC conjugated, eBiosciences), IL-6 (clone MQ2-13A5, FITC conjugated, eBiosciences), IL-10 (clone JES3-9D7, Alexa Fluor 488 conjugated, eBiosciences), HLA-DR (clone L243, APC.Cy7 conjugated, BD Biosciences), CD33 (clone P67.6, PE conjugated, BD Biosciences), CD11b (clone D12, APC conjugated, BD Biosciences), CD14 (clone MɸP9, Brilliant Violet 421 conjugated, BD Biosciences) and Arginase-1 (ARG-1, FITC-conjugated, R&D Systems). Isotype controls were used for each experiment. After incubation, cells were again washed, resuspended in flow buffer and analyzed using FACSCalibur and FACSCanto II cytometers (BD, Biosciences). At least 5 × 104 events were collected, and the data was analyzed using Summit software (Summit Group Software).
+ Open protocol
+ Expand
4

Intracellular IL-2 Measurement in T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells, neutrophils and ASC were plated as described in T-cell suppression assays. Brefeldin A (10μg/mL; cat. #B7651-5MG, Sigma-Aldrich) was added at 4 and 18hrs after incubation and intracellular IL2 was measured 6hrs later (10 and 24hrs, respectively). Cells were stained with antibodies specific for CD4 (clone RPA-T4; cat. #562425, BD Biosciences) and CD8 (clone SK1; cat. #344706, Biolegend). Cells were fixed with 1x IC Fixing buffer (cat. #00-8222-49, eBiosciences) for 10 minutes, washed, resuspended in 1X Permeabilization Buffer (cat. #00-5523-00, eBiosciences), stained with an antibody specific for IL2 (clone MQ1-17H12; cat. #561054, BD Biosciences) for 25 minutes, then washed with 1X Permeabilization Buffer, and analyzed by flow cytometry.
+ Open protocol
+ Expand
5

Flow Cytometry Analysis of CAR T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A FACSCanto II (BD Biosciences) instrument was used to acquire flow cytometry data, which was analyzed using FlowJo v10.7 (BD Biosciences). For surface staining, samples were washed with and stained in PBS (Lonza) with 1% FBS (GE Healthcare). For all experiments, matched isotypes or known negatives (e.g. nontransduced T cells or B7-H3-negative cell lines) served as gating controls. CAR detection was performed using F(ab’)2 fragment-specific antibody (polyclonal, Jackson ImmunoResearch, West Grove, PA, USA). T cells were stained with fluorochrome-conjugated antibodies using combinations of the following markers: CD4 (clone SK3, BD Biosciences), CD8 (clone SK1, BD Biosciences), CCR7 (clone G043H7, BioLegend, San Diego, CA, USA), and CD45RO (clone UCHL1, BD Biosciences). LM7 and the negative control leukemia cell line BV173 were evaluated for expression of B7-H3 using B7-H3 antibody (clone 7-517, BD Biosciences, or clone FM276, Miltenyi). Cells were additionally stained with DAPI (BD Biosciences) to gate for live cells.
+ Open protocol
+ Expand
6

Flow Cytometric Analysis of CAR T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A FACSCanto II (BD Biosciences) instrument was used to acquire flow cytometry data, which was analyzed using FlowJo v10 (BD Biosciences). For surface staining, samples were washed with and stained in PBS (Lonza) with 1% FBS (GE Healthcare). For all experiments, matched isotypes or known negatives (e.g., NT T cells) served as gating controls. CAR detection was performed using F(ab′)2 fragment=specific antibody (polyclonal, Jackson ImmunoResearch, West Grove, PA, USA). T cells were stained with fluorochrome-conjugated antibodies using combinations of the following markers: CD4 (clone SK3, BD Biosciences), CD8 (clone SK1, BD Biosciences), CCR7 (clone G043H7, BioLegend, San Diego, CA, USA), CD45RO (clone UCHL1, BD Biosciences), and 41BBL (clone 5F4, BioLegend). Tumor cell lines were evaluated for expression of B7-H3 using B7-H3 antibody (clone 7-517, BD Biosciences, or clone FM276, Miltenyi). To determine apoptosis, T cells were labeled with annexin V (BD Biosciences) and DAPI (BD Biosciences). The percentages of apoptotic cells were determined by the percent annexin V positive.
+ Open protocol
+ Expand
7

Quantifying Tumor-Infiltrating T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were resuspended in FACS staining buffer (PBS + 3% fetal bovine serum) using the following antibodies: CD3 (clone OKT3, eBiosciences), CD4 (clone OKT4, eBiosciences), CD8 (clone SK1, BD), PD-1 (clone J105, eBiosciences), TIM3 (clones F38–2E2, BioLegend), Tbet (clone 4B10, eBiosciences). CD19 CAR was detected using an anti-idiotype antibody provided by Novartis Pharmaceuticals. All changes in overall tumor or T cell counts reflect changes in absolute cell counts, which were determined using CountBright absolute counting beads (ThermoFisher). Cell viability was established using Live/Dead Aqua fixable staining kit (ThermoFisher), and data were acquired on an LSRII Fortessa Cytometer (BD). All data analysis was performed using FlowJo 9.0 software (FlowJo, LLC).
+ Open protocol
+ Expand
8

Characterization of Mtb-specific T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Because of the abundance of Mtb antigens already present in granulomas and involved lymph nodes (Gideon et al., 2015 (link)), these samples were not further stimulated with Mtb peptides (Gideon et al., 2015 (link)). Due to low number of cells, uninvolved lung lobes were also not stimulated. All samples were incubated in the presence of Brefeldin A (GolgiPlug, BD Biosciences) at 37°C/5% CO2 for 3.5-4 hours prior to staining. Cells were stained with a viability marker (LIVE/DEAD fixable blue dead cell stain kit, Invitrogen) and surface and intracellular markers. Surface markers include CD3 (clone SP34-2, BD Pharmingen), CD4 (Clone L200, BD Horizon), CD8 (Clone SK1, BD Biosciences) and CD20 (Clone 2H7, eBioscience).
+ Open protocol
+ Expand
9

Multiparameter Phenotyping of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained with fluorochrome-conjugated Abs specific for CXCR5 (clone MU5UBEE; eBioscience), CD3 (clone SP-34-2; BD Biosciences), CXCR3 (clone IC6; BD Biosciences), CCR6 (clone 11A9), CCR4 (clone 1G1), ICOS (clone C398.4A; ebioscience), CD95 (clone; BD Biosciences), PD-1(Clone EH12.1; Biolegend), CD8 (Clone SK1; BD Bioscience), CD4 (clone; OKT4; biolegend), CCR5 (Clone 3A9, BD Biosciences), α4β7 (Act1, NHP reagent resource), Live Dead-IR stain (Invitrogen), Ki-67 (Clone B56; BD Biosciences), Bcl-6 (clone K112-91), IL-21 (Clone 3A3-N2; BD Biosciences), CD4 (Clone L200; BD Biosciences), Alexa700 conjugated IFNγ (Clone B27; BD Biosciences). FITC conjugated CD40L (Clone TRAP1; BD Biosciences).
+ Open protocol
+ Expand
10

Profiling Immune Landscapes in Glioma Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh tumor tissues were obtained from 20 patients undergoing surgical resection of glioma in accordance with the institutional review board approval at Seoul National University Hospital. Histological diagnosis consisted of 10 glioblastomas, 4 anaplastic oligodendrogliomas, 3 anaplastic astrocytomas, 1 diffuse midline glioma, 1 anaplastic ganglioglioma, and 1 oligodendroglioma. Tumor specimens were collected in RPMI media at room temperature immediately after surgical resection. MACS brain tumor dissociation kit and gentleMACS™ Dissociators (Miltenyi Biotec) were used to dissociate tissue samples within 2 hours following collection, and debris were removed using MACS Debris Removal Solution (Miltenyi Biotec) according to the manufacturer protocol.
Immune cells were stained for surface markers using fluorescence-conjugated monoclonal antibodies including CD45 (clone HI30, BD Biosciences), CD3 (clone UCHT1, BD Biosciences), CD4 (clone L200, BD Biosciences), CD8 (clone SK1, BD Biosciences), PD1 (clone EH12.1, BD Biosciences), and TIGIT (clone 741182, R&D Systems). Flow cytometry was performed using FACS LSR Fortessa™ (BD Biosciences), and data was analyzed using FlowJo software (Treestar).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!